HIGHFDA DRUG
Trifecta Pharmaceuticals Recalls Clotrimazole Cream Over cGMP Issues
Trifecta Pharmaceuticals recalled 14,700 bottles of Globe Clotrimazole Cream USP on October 31, 2025, due to significant cGMP deviations. The affected product may not meet necessary safety and quality standards. Consumers should stop using the cream immediately and seek guidance from healthcare providers.
CLOTRIMAZOLE
cGMP deviations